85 related articles for article (PubMed ID: 8547090)
1. CD34+ cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass.
Kanold J; Berger M; Rapatel C; de Lumley L; Lutz P; Plantaz D; Vannier JP; Bergeron C; Mechinaud F; Favrot M
Br J Haematol; 1995 Oct; 91(2):431-3. PubMed ID: 8547090
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small children.
Berger M; Kanold J; Rapatel C; deLumley L; Lutz P; Plantaz D; Vannier JP; Mechinaud F; Bergeron C; Favrot M; Gembara P; Halle-Hauss P; Bonhomme J; Travade P; Deméocq F
Bone Marrow Transplant; 1997 Aug; 20(3):191-8. PubMed ID: 9257886
[TBL] [Abstract][Full Text] [Related]
3. Optimal blood stem cell mobilization using 10 micrograms/kg granulocyte colony-stimulating factor (G-CSF) alone for high-dose melphalan intensification in multiple myeloma: an intrapatient controlled study.
Feremans W; Le Moine F; Ravoet C; Lambermont M; Bastin G; Delville JP; Pradier O; Dupont E; Capel P
Am J Hematol; 1994 Oct; 47(2):135-8. PubMed ID: 7522395
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis.
Luider J; Brown C; Selinger S; Quinlan D; Karlsson L; Ruether D; Stewart D; Klassen J; Russell JA
J Hematother; 1997 Dec; 6(6):575-80. PubMed ID: 9483192
[TBL] [Abstract][Full Text] [Related]
6. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
[TBL] [Abstract][Full Text] [Related]
7. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
8. CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastoma.
Marabelle A; Merlin E; Halle P; Paillard C; Berger M; Tchirkov A; Rousseau R; Leverger G; Piguet C; Stephan JL; Demeocq F; Kanold J
Pediatr Blood Cancer; 2011 Jan; 56(1):134-42. PubMed ID: 21058288
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
[TBL] [Abstract][Full Text] [Related]
10. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648
[TBL] [Abstract][Full Text] [Related]
11. G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma.
Mahé B; Milpied N; Hermouet S; Robillard N; Moreau P; Letortorec S; Rapp MJ; Bataille R; Harousseau JL
Br J Haematol; 1996 Feb; 92(2):263-8. PubMed ID: 8602984
[TBL] [Abstract][Full Text] [Related]
12. Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields.
Weaver CH; Tauer K; Zhen B; Schwartzberg LS; Hazelton B; Weaver Z; Lewkow L; Allen C; Longin K; Buckner CD
J Hematother; 1998 Jun; 7(3):241-9. PubMed ID: 9621257
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of CD34(+) cell transplantation in children with neuroblastoma.
Kanold J; Yakouben K; Tchirkov A; Carret AS; Vannier JP; LeGall E; Bordigoni P; Deméocq F
Med Pediatr Oncol; 2000 Jul; 35(1):1-7. PubMed ID: 10881000
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
15. CD34⁺ collection efficiency as a function of blood volumes processed in pediatric autologous peripheral blood stem cell collection.
Dubrovsky L; Wong EC; Perez-Albuerne E; Loechelt B; Kamani N; Sande J; Mintz K; Paul W; Luban NL; Rood BR; Fry T
J Clin Apher; 2011; 26(3):131-7. PubMed ID: 21294153
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of peripheral blood stem cell (PBSC) and peripheral blood mononuclear cell (PBMNC) separation in children with a body weight below 20 KG.
Urban C; Schwinger W; Benesch M; Lackner H; Kerbl R; Gilli R; Pätzold U; Burdach S
Med Pediatr Oncol; 1997 Aug; 29(2):115-20. PubMed ID: 9180913
[TBL] [Abstract][Full Text] [Related]
17. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
[TBL] [Abstract][Full Text] [Related]
18. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
Knudsen LM; Gaarsdal E; Jensen L; Nielsen KJ; Nikolaisen K; Johnsen HE
J Hematother; 1996 Aug; 5(4):399-406. PubMed ID: 8877715
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
